Showing 731-740 of 1782 results for "".
The History of Research Into Vaccines for Shingles
https://reachmd.com/programs/clinicians-roundtable/the-history-of-research-into-vaccines-for-shingles/2725/Decades of research have gone into the isolation and refinement of a vaccine for adult shingles, approved in 2006 by the FDA and in use today. Do we now fully understand the mechanism which activates the latent varicella-zoster virus, leading to adult shingles? How did initial isolation, going backGestational Diabetes--Treatment Controversies
https://reachmd.com/programs/clinicians-roundtable/gestational-diabetes-treatment-controversies/1795/Is there a role for oral hypoglycemic agents in the treatment of gestational diabetes? Do women with normal glucose tolerance on insulin have an increased risk of neonatal morbidity over that of non-diabetic women? Our guest is Dr. Thomas Moore, Professor and Chairman of the Department of ReprEvaluating the Rapid Rise of T1D in Children Amid the COVID-19 Pandemic
https://reachmd.com/programs/diabetes-discourse/evaluating-the-rapid-rise-of-t1d-in-children-amid-the-covid-19-pandemic/13527/Find out why the rate of type 1 diabetes in children had grown throughout the pandemic—and what we can do to overcome this obstacle.The Clinical Weight of TTR: What the Latest Data Reveal
https://reachmd.com/programs/cme/the-clinical-weight-of-ttr-what-the-latest-data-reveal/35934/Review emerging data on acoramidis and TTR levels in ATTR-CM, exploring associations with AFib, survival outcomes, biomarkers, and comorbidity burden.Sjögren’s Disease Management: A Decade in Review
https://reachmd.com/programs/living-rheum/sjogrens-disease-management-a-decade-in-review/36342/CGM in the Real T2D World
https://reachmd.com/programs/cme/cgm-real-t2d-world/50982/Continuous glucose monitoring (CGM) is still recommended for all individuals with diabetes, including those with type 2 diabetes (T2D). Despite this, its use in managing T2D has not been as widespread as expected. New evidence has recently highlighted the benefits of CGM for people with T2D. Join ouArtificial Intelligence in Clinical Neurology: Opportunities, Limitations, and the Path Forward
https://reachmd.com/diseases-diagnoses/imaging-testing/artificial-intelligence-in-clinical-neurology-opportunities-limitations-and-the-path-forward/56386/Artificial intelligence is revolutionizing clinical neuroimaging by enhancing how neurologic conditions are diagnosed, prioritized, and managed, but its challenges must be addressed to ensure safe and fair use across diverse patient populations.Exploring Patient Perspectives on Genetic Testing for ATTR-CM
https://reachmd.com/programs/on-the-frontlines-of-attr-cm/exploring-patient-perspectives-on-genetic-testing-for-attr-cm/39317/Genetic testing is a very valuable tool in managing transthyretin amyloid cardiomyopathy (ATTR-CM), but many patients face emotional, educational, and systemic barriers throughout. To learn more about the patient perspective of this process, researchers conducted interviews with ATTR-CM patients andPeripheral Nerve Stimulation for Acute Pain: Lessons from Early and Ongoing Trials
https://reachmd.com/programs/clinicians-roundtable/peripheral-nerve-stimulation-for-acute-pain-lessons-from-early-and-ongoing-trials/26730/Tune in to learn about key findings from early studies and ongoing trials focusing on peripheral nerve stimulation for acute pain.Challenging Common Misconceptions About Vitiligo
https://reachmd.com/programs/dermconsult/challenging-common-misconceptions-about-vitiligo/13973/While our understanding of vitiligo has come a long way, there are still many misconceptions about this disease. What do we need to know about them?